3D Bioprinting Market Size, Share, Opportunity, Opportunity and Industry Forecast, 2022-2030
3D Bioprinting Market Overview
It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old-age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale. Numerous factors are adding to the global 3D bioprinting market growth. These factors, according to the recent Market Research Future report, include growing need for transplantation of organs, rising investment in R&D activities, increasing geriatric population, technological advances to manufacture custom made products, innovations, and developments in 3D bioprinting, and increasing use in cosmetic surgery and drug discovery. , the cost-effective nature of the technology is expected to drive the market demand as well. Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth. One of the major traction provider for the market is its cost-effective productions. Hike in the demand for implants and prosthetics are making sure that this market gets good scope for growth. In addition, surging number of players going in for the market opens up possibilities regarding innovation, further curbing of cost, variety in range, and others.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Market Players
Leading manufacturers and the 3D bioprinting market top companies like 3D Systems, Inc., GE Healthcare, Electro-Optical Systems, Stratasys Ltd., and Renishaw PLC. dominate the global market. By providing a broad spectrum of 3D bioprinting, major manufacturers are concentrating on the development of intermediates. Additionally, the market's major competitors focus on strengthening their regional and worldwide footprint through acquisitions and expansions. For instance, in conjunction with United Therapeutics Corporation, 3D Systems stated in February 2019 that it was expanding its line of regenerative and bioprinting solutions in January 2021.
Some of the critical 3D bioprinting companies are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), and Cyfuse Biomedical K.K. (Japan).
3D Bioprinting Market Market Segmentation
By technologies, the market includes magnetic 3D bioprinting, inkjet 3D bioprinting, laser-assisted bioprinting, and microextrusion bioprinting. The microextrusion bioprinting is expected to grow significantly during the forecast period. Additionally, Inkjet 3D bioprinting segment is also anticipated to hold a significant share of the market due to its compatibility with living cells.
By material, the market includes living cells, extracellular matrices, hydrogels, and others. The living cells segment hold a major portion of the share due to its manufacturing using in-air microfluidics. Hydrogels segment is too expected to garner high demand in the forthcoming years.
By application, the market divides into clinical and research applications. It is expected for the clinical applications segment to pose a higher market share due to the demand of organ transplantation.
By end-user, the market segments into pharmaceutical & biotechnology companies and research organization & academic institutes. Both the segments are expected to grow in numbers in the forthcoming years.
3D Bioprinting Market Market Regional Analysis
The geographical segmentation of the global 3D bioprinting market is focused upon regions like Asia Pacific, the Americas, Europe, and the Middle East & Africa.
As per the last conducted study in 2017, the Americas held the highest share of the market due to considerable increase in research & development activities, existence of a large patient pool, development of healthcare infrastructure, and increasing budget expenditure of healthcare in countries like the US and Canada.
The European region held the second position in the global standings in terms of market share. This is primarily due to the surging investment in 3D printing and a high demand in countries like the UK, France, and Germany. Additionally, increasing application of the 3D bioprinting technology in the cosmetic sector alongside the band on animal testing are key factors that can further push the market growth in this region.
The Asia Pacific region is expected to garner the highest growth percentage over the forecast period due to the developing healthcare industry in China and other emerging economies. Also, collaboration among leading companies to set-up units, and increasing funding for research and development activities are expected to push the growth of the region further.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
